We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at…
Jérémie Meyer24.06.2020
There is an opportunity to participate in a research study interview taking place for those with knowledge of the biopharmaceutical industry in Switzerland. The research should…
Jérémie Meyer11.05.2020
We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing…
Jérémie Meyer11.05.2020
“Go start a biotech company in a strong biotech ecosystem” is our conclusion from this Nature paper, which tracks down every biotech start-up emerging (between…
Jérémie Meyer08.05.2020
From our partner, KPMG: Proving an online knowledge base for the COVID-19 times. KPMG has put together an online resource page for these challenging and…
Jérémie Meyer08.05.2020
ImmunOs Therapeutics AG is a Swiss biotechnology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer. They have recently…
Jérémie Meyer17.12.2019
From our partner, KPGM: The rules of engagement in the global pharmaceutical industry are changing rapidly with disruption in this industry already well underway. Two…
Jérémie Meyer06.12.2019
The selection committee has chosen 15 promising projects for Phase I. The projects all focus on developing innovative technologies to dramatically change patient outcomes in a variety…
Jérémie Meyer03.10.2019
Switzerland is consistently ranked the most innovative country in the world, especially when it comes to life sciences. Abi Millar, from Pharma Technology Focus, looks…
Jérémie Meyer03.10.2019
